Literature DB >> 8945613

Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer.

M Mori1, H Inoue, T Shiraishi, K Mimori, K Shibuta, H Nakashima, K Mafune, Y Tanaka, H Ueo, G F Barnard, K Sugimachi, T Akiyoshi.   

Abstract

Paternal allele-specific expression is identified for the insulin-like growth factor 2 (IGF2) gene. Relaxation or loss of IGF2 imprinting, however, has been reported in several neoplasms. We studied the expression of IGF2 mRNA in 35 squamous cancers of the esophagus and searched for the presence or absence of relaxation of IGF2 imprinting. In 28 (80%) cases, IGF2 mRNA was overexpressed in the tumor tissues (T) compared to the normal tissues (N). The patients whose tumor invaded the adventitia showed a higher T/N ratio than those whose tumor was restricted to the musculi propria layer. Heterozygosity was determined by using the Apa I polymorphism in exon 9. Thirteen of 35 cases showed heterozygosity. In these 13 cases, a similar analysis was performed on cDNA obtained by reverse transcriptase-polymerase chain reaction. Consequently, 7 cases disclosed relaxation of IGF2 imprinting in the tumor tissue. The cases of esophageal cancer with relaxation of IGF2 imprinting showed a higher T/N ratio and deeper invasion than those without relaxation. The results suggest that overexpression of IGF2 mRNA plays an important role in esophageal cancer and, in certain cases, is associated with relaxation of IGF2 imprinting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945613     DOI: 10.1002/(SICI)1097-0215(19961115)68:4<441::AID-IJC7>3.0.CO;2-0

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.

Authors:  Yasushi Adachi; Hirokazu Ohashi; Arisa Imsumran; Hiroyuki Yamamoto; Yasutaka Matsunaga; Hiroaki Taniguchi; Katsuhiko Nosho; Hiromu Suzuki; Yasushi Sasaki; Yoshiaki Arimura; David P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Tumour Biol       Date:  2013-09-13

Review 2.  Genomic imprinting and cancer.

Authors:  J A Joyce; P N Schofield
Journal:  Mol Pathol       Date:  1998-08

3.  A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers.

Authors:  Yasushi Adachi; Hiroyuki Yamamoto; Hirokazu Ohashi; Takao Endo; David-P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

4.  IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.

Authors:  Munenori Takaoka; Seok-Hyun Kim; Takaomi Okawa; Carmen Z Michaylira; Douglas B Stairs; Cameron N Johnstone; Claudia D Andl; Ben Rhoades; James J Lee; Andres J P Klein-Szanto; Wafik S El-Deiry; Hiroshi Nakagawa
Journal:  Cancer Biol Ther       Date:  2007-04       Impact factor: 4.742

5.  H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.

Authors:  T Gao; B He; Y Pan; L Gu; L Chen; Z Nie; Y Xu; R Li; S Wang
Journal:  Clin Transl Oncol       Date:  2013-08-13       Impact factor: 3.405

6.  Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.

Authors:  Chang-Qi Zhu; Svetlana N Popova; Ewan R S Brown; Dalia Barsyte-Lovejoy; Roya Navab; Warren Shih; Ming Li; Ming Lu; Igor Jurisica; Linda Z Penn; Donald Gullberg; Ming-Sound Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-28       Impact factor: 11.205

7.  Decreased expression of p57(KIP2)mRNA in human bladder cancer.

Authors:  M Oya; W A Schulz
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

8.  Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.

Authors:  Stefan Küffer; Tobias Gutting; Djeda Belharazem; Christian Sauer; Maurice S Michel; Alexander Marx; Lutz Trojan; Philipp Ströbel
Journal:  Mol Oncol       Date:  2018-01-04       Impact factor: 6.603

9.  Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.

Authors:  Yasushi Adachi; Masanori Nojima; Mitsuru Mori; Kentaro Yamashita; Hiro-O Yamano; Hiroshi Nakase; Takao Endo; Kenji Wakai; Kiyomi Sakata; Akiko Tamakoshi
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

Review 10.  Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.

Authors:  Jalil Pirayesh Islamian; Mohsen Mohammadi; Behzad Baradaran
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.